One year in review 2020: gout

Area of Science:

• Rheumatology
• Inflammatory Arthritis Research
• Gout Pathogenesis

Background:

• Gout is a widespread inflammatory arthritis with significant health and economic burdens.
• Understanding gout's complexities is crucial for effective patient management and public health strategies.
• Recent advancements necessitate a consolidated review of current knowledge.

Purpose of the Study:

• To provide a comprehensive overview of clinical and experimental evidence on gout published in 2019.
• To synthesize new insights into gout's genetic factors, pathogenesis, and risk profiles.
• To update knowledge on therapeutic interventions, lifestyle influences, and emerging research models.

Main Methods:

• Systematic review of clinical and experimental studies on gout from 2019.
• Epidemiological analysis of gout prevalence and trends.
• Inclusion of research on genetic predispositions, disease mechanisms, and comorbidities.
• Evaluation of pharmacological treatments, dietary factors, and lifestyle modifications.
• Analysis of novel animal models for studying acute gout flares.

Main Results:

• New genetic factors influencing gout flare susceptibility have been identified.
• Updated understanding of pathogenetic mechanisms and associated risk factors for gout.
• Comorbidities associated with gout have been further elucidated.
• Recent data on the efficacy of pharmacological therapies and the impact of lifestyle choices were presented.
• Novel insights from animal models offer new perspectives on monosodium urate crystal-induced inflammation.

Conclusions:

• The review highlights significant progress in understanding gout's multifaceted nature in 2019.
• Advances in genetics, pathogenesis, and treatment offer improved strategies for gout management.
• The renewed focus on animal models signifies a promising direction for future gout research.